AGC Biologics’ cell and gene therapy platform, anchored in autologous CD34+ hematopoietic stem and progenitor cells transduced with lentiviral vectors, is directly applicable to the kinds of programs OTXL is onboarding.
AGC Biologics’ cell and gene therapy platform, anchored in autologous CD34+ hematopoietic stem and progenitor cells transduced with lentiviral vectors, is directly applicable to the kinds of programs OTXL is onboarding.